Satavaptan Uses, Dosage, Side Effects and more
Satavaptan is under investigation in clinical trial NCT00359437 (Satavaptan in the Prevention of Ascites Recurrence in Patients With Ascites Due to Cirrhosis of the Liver).
| Trade Name | Satavaptan |
| Generic | Satavaptan |
| Satavaptan Other Names | Satavaptan |
| Type | |
| Formula | C33H45N3O8S |
| Weight | Average: 643.8 Monoisotopic: 643.292736595 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
